tiprankstipranks
Trending News
More News >
Fine Foods & Pharmaceuticals N.T.M. SpA (IT:FF)
:FF
Italy Market

Fine Foods & Pharmaceuticals N.T.M. SpA (FF) Price & Analysis

Compare
6 Followers

FF Stock Chart & Stats


---

Bulls Say, Bears Say

Bulls Say
Growth PotentialManagement remains confident on growth with a strong order backlog and multi-year contracts supporting historical revenue and margin growth trends.
Market PositionFine Foods benefits from its position as Italy's largest CDMO and its flexibility to act as a natural consolidator in the market.
ProfitabilityRecord profitability was boosted by the Cosmetics repositioning, contributing to improved margins and profitability.
Bears Say
Business Unit ChallengesGroup revenues came to €177mn, reflecting a decrease due to challenges in the Cosmetics and Nutra business units.
Revenue ChallengesThe Nutra business unit is expected to have slower growth assumptions, leading to a slight reduction in group revenue.
Revenue DeclineA relatively challenging YoY comparison and different order phasing led to a drop in group revenues.
---

Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.02%99.98%
0.02%
Mutual Funds
― Other Institutional Investors
99.98% Public Companies and
Individual Investors

FF FAQ

What was Fine Foods & Pharmaceuticals N.T.M. SpA’s price range in the past 12 months?
Fine Foods & Pharmaceuticals N.T.M. SpA lowest stock price was €6.46 and its highest was €9.62 in the past 12 months.
    What is Fine Foods & Pharmaceuticals N.T.M. SpA’s market cap?
    Fine Foods & Pharmaceuticals N.T.M. SpA’s market cap is €181.85M.
      When is Fine Foods & Pharmaceuticals N.T.M. SpA’s upcoming earnings report date?
      Fine Foods & Pharmaceuticals N.T.M. SpA’s upcoming earnings report date is Aug 05, 2025 which is in 84 days.
        How were Fine Foods & Pharmaceuticals N.T.M. SpA’s earnings last quarter?
        Fine Foods & Pharmaceuticals N.T.M. SpA released its earnings results on May 08, 2025. The company reported €0.165 earnings per share for the quarter, beating the consensus estimate of N/A by €0.165.
          Is Fine Foods & Pharmaceuticals N.T.M. SpA overvalued?
          According to Wall Street analysts Fine Foods & Pharmaceuticals N.T.M. SpA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Fine Foods & Pharmaceuticals N.T.M. SpA pay dividends?
            Fine Foods & Pharmaceuticals N.T.M. SpA pays a Annually dividend of €0.259 which represents an annual dividend yield of 1.59%. See more information on Fine Foods & Pharmaceuticals N.T.M. SpA dividends here
              What is Fine Foods & Pharmaceuticals N.T.M. SpA’s EPS estimate?
              Fine Foods & Pharmaceuticals N.T.M. SpA’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Fine Foods & Pharmaceuticals N.T.M. SpA have?
              Fine Foods & Pharmaceuticals N.T.M. SpA has 22,060,125 shares outstanding.
                What happened to Fine Foods & Pharmaceuticals N.T.M. SpA’s price movement after its last earnings report?
                Fine Foods & Pharmaceuticals N.T.M. SpA reported an EPS of €0.165 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 6.111%.
                  Which hedge fund is a major shareholder of Fine Foods & Pharmaceuticals N.T.M. SpA?
                  Currently, no hedge funds are holding shares in IT:FF
                  ---

                  Company Description

                  Fine Foods & Pharmaceuticals N.T.M. SpA

                  Fine Foods & Pharmaceuticals N.T.M. SpA (FF) is a leading Italian contract development and manufacturing organization (CDMO) specializing in the production of pharmaceuticals, nutraceuticals, and cosmetics. The company operates within the health and wellness sectors, offering a comprehensive range of services from product development to manufacturing and packaging. FF is known for its commitment to quality and innovation, serving a diverse clientele that includes major pharmaceutical and consumer health companies.
                  ---

                  FF Stock 12 Month Forecast

                  Average Price Target

                  €11.50
                  ▲(52.93% Upside)
                  {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"€5","12":"€12","6.75":"€6.75","8.5":"€8.5","10.25":"€10.25"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":11.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€11.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€11.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€11.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,6.75,8.5,10.25,12],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2023","6":"Sep<br/>2023","9":"May<br/>2024","12":"Mar<br/>2025","25":"Mar<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.49,6.875384615384616,7.260769230769231,7.6461538461538465,8.031538461538462,8.416923076923077,8.802307692307693,9.187692307692307,9.573076923076924,9.958461538461538,10.343846153846155,10.72923076923077,11.114615384615384,{"y":11.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.49,6.875384615384616,7.260769230769231,7.6461538461538465,8.031538461538462,8.416923076923077,8.802307692307693,9.187692307692307,9.573076923076924,9.958461538461538,10.343846153846155,10.72923076923077,11.114615384615384,{"y":11.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.49,6.875384615384616,7.260769230769231,7.6461538461538465,8.031538461538462,8.416923076923077,8.802307692307693,9.187692307692307,9.573076923076924,9.958461538461538,10.343846153846155,10.72923076923077,11.114615384615384,{"y":11.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.96,"date":1669852800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":7.96,"date":1672531200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":7.82,"date":1675209600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":7.92,"date":1677628800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":7.92,"date":1677628800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.39,"date":1682899200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.01,"date":1693526400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.38,"date":1698796800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.02,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.34,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.1,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.18,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.49,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Reply SPA
                  CIR SpA - Compagnie Industriali Riunite
                  Popular Stocks
                  ---
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis